BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Dabigatran impurity 84 | Dabigatran impurity 84 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C29H33N6O4Cl. Mole weight: 565.08. |  |
| Dabigatran impurity 85 | Dabigatran impurity 85 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C34H41N7O5. Mole weight: 627.75. | |
| Dabigatran impurity 90 | Dabigatran impurity 90 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Synonyms: Ethyl 3-(3-(2-((4-cyanophenyl)amino)acetamido)-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate. CAS No. 948551-71-1. Molecular formula: C27H28N6O4. Mole weight: 500.56. | |
| Dabigatran impurity 91 | Dabigatran impurity 91 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C21H22N6O2. Mole weight: 390.45. | |
| Dabigatran impurity 92 | Dabigatran impurity 92 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C18H20N4O4. Mole weight: 356.38. | |
| Dabigatran impurity 93 | Dabigatran impurity 93 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C36H40N8O7. Mole weight: 696.77. | |
| Dabigatran impurity 94 | Dabigatran impurity 94 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C36H40N8O6. Mole weight: 680.77. | |
| Dabigatran impurity 95 | Dabigatran impurity 95 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Synonyms: Diethyl 3,3'-((3,3'-(hydrazine-1,2-diyl)bis(4-(methylamino)benzoyl))bis(pyridin-2-ylazanediyl))dipropionate. Molecular formula: C36H42N8O6. Mole weight: 682.78. | |
| Dabigatran impurity 96 | Dabigatran impurity 96 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C18H22N4O4. Mole weight: 358.4. | |
| Dabigatran Impurity 97 | Dabigatran Impurity 97 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C48H65N7O9. Mole weight: 884.09. | |
| Dabigatran Impurity 98 | Dabigatran Impurity 98 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C31H32N6O10. Mole weight: 648.63. | |
| Dabigatran Isopropyl Ester Impurity | Dabigatran Isopropyl Ester Impurity is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. CAS No. 1610758-17-2. Molecular formula: C28H31N7O3. Mole weight: 513.6. | |
| Dabigatran Methyl Ester Impurity | Dabigatran Methyl Ester Impurity is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. CAS No. 771459-37-1. Molecular formula: C26H27N7O3. Mole weight: 485.55. | |
| Dacarbazine | Dacarbazine is an antineoplastic chemotherapy drug used in the treatment of various cancers.Dacarbazine is a member of the class of alkylating agents, which destroy cancer cells by adding an alkyl group (CnH2n+1) to its DNA. Uses: Anti-tumor. Synonyms: DTIC-Dome. Grades: >98%. CAS No. 4342-3-4. Molecular formula: C6H10N6O. Mole weight: 182.18. | |
| Dacarbazine Impurity A | 2-Azahypoxanthine, is an impurity of Dacarbazine, which is used as an antineoplastic for treatment of various cancers such as, malignant melanoma and sarcomas. Synonyms: 2-Azahypoxanthine; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one; 1,5-Dihydro-4H-Imidazo[4,5-d]-1,2,3-triazin-4-one; 3,7-Dihydro-4H-imidazo[4,5-d]-v-triazin-4-one. Grades: > 95%. CAS No. 4656-86-4. Molecular formula: C4H3N5O. Mole weight: 137.1. | |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Synonyms: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grades: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6ยท2HCl. Mole weight: 811.8. | |
| Daclatasvir Impurity 4 | Daclatasvir RSSR Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir RSSR Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
| Dacomitinib Impurity DF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H26FN5O2. Mole weight: 435.50. | |
| Dacomitinib Impurity DFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity); N4-(4-FLUOROPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE; Dacomitinib Impurity DFAJ; CS-0255390; F83326. Grades: ≥95%. CAS No. 1562180-31-7. Molecular formula: C15H13FN4O. Mole weight: 284.29. | |
| Dacomitinib Impurity DFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 2185841-22-7. Molecular formula: C15H11FN4O3. Mole weight: 314.27. | |
| Dacomitinib Impurity E | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Impurity SF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25F2N5O2. Mole weight: 453.49. | |
| Dacomitinib Impurity SFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: Dacomitinib Impurity SFAJ; CS-0255393; F83329; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine; N4-(3,4-DIFLUOROPHENYL)-7-METHOXY-QUINAZOLINE-4,6-DIAMINE; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity). Grades: ≥95%. CAS No. 2117703-26-9. Molecular formula: C15H12F2N4O. Mole weight: 302.28. | |
| Dacomitinib Impurity SFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 2119689-75-5. Molecular formula: C15H10F2N4O3. Mole weight: 332.26. | |
| Dacomitinib Impurity SL | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25Cl2N5O2. Mole weight: 486.40. | |
| Dacomitinib Impurity SLAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12Cl2N4O. Mole weight: 335.19. | |
| Dacomitinib Impurity SLXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10Cl2N4O3. Mole weight: 365.17. | |
| Dacomitinib Impurity WZYG | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity WZYGAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.74. | |
| Dacomitinib Impurity WZYGXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| (D-Ala2,D-Leu5)-Enkephalin Trifluoroacetate | (D-Ala2,D-Leu5)-Enkephalin is a prototypical δ-opioid receptor agonist with antinociceptive activity. It also exhibits activity at the μ-opioid receptor. Synonyms: L-tyrosyl-D-alanyl-glycyl-L-phenylalanyl-D-leucine trifluoroacetic acid; (D-Ala2,D-Leu5)-Enkephalin TFA salt; DADLE TFA salt. Molecular formula: C31H40F3N5O9. Mole weight: 683.67. | |
| Dalbavancin | Dalbavancin is a semi-synthetic glycopeptide by introducing a positively charged lipophilic moiety in a previously unexplored region of the natural glycopeptide. This modification provides a longer in vivo half life, and improved in vitro activity against a variety of Gram-positive and multi-drug resistant isolates such as MRSA and MRSE. Synonyms: dalbavancin B0; BI397. Grades: >98%. CAS No. 171500-79-1. Molecular formula: C88H100Cl2N10O28. Mole weight: 1816.69. | |
| Dalcetrapib | Dalcetrapib is a potent CETP inhibitor that increases the HDL level and decreases the VLDL level in plasma. It exhibits cardiovascular protective property. Uses: Anticholesteremic agents. Synonyms: JTT-705; JTT705; JTT 705; RO-4607381; RO4607381; RO 4607381; S-[2-[[1- (2-ethylbutyl) cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate. Grades: >98%. CAS No. 211513-37-0. Molecular formula: C23H35NO2S. Mole weight: 389.59. | |
| D-allo-Thr(6)-Octreotide | D-allo-Thr(6)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-allo-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); D-Phe-Cys-Phe-D-Trp-Lys-D-allo-Thr-Cys-Thr-ol (Disulfide Bridge between Cys2-Cys7); Octreotide EP impurity-A; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-allo-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide. CAS No. 1546983-12-3. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. | |
| DAMPA Ethyl Ester | DAMPA Ethyl Ester is an analog of Methotrexate, which is a folic acid antagonist used as an antineoplastic and antirheumatic. Uses: A methotrexate analog with altered ester group. Synonyms: 4-[[ (2, 4-Diamino-6-pteridinyl) methyl]methylamino]benzoic Acid Ethyl Ester; Ethyl p-[[ (2, 4-Diamino-6-pteridinyl) methyl]methylamino]benzoate; NSC 694477. Grades: ≥95%. CAS No. 43111-51-9. Molecular formula: C17H19N7O2. Mole weight: 353.38. | |
| Danofloxacin Mesylate | Danofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase. Uses: Anti-infective agents. Synonyms: CP-76136-27. Grades: >98%. CAS No. 119478-55-6. Molecular formula: C19H20FN3O3.CH4O3S. Mole weight: 453.48. | |
| Dantrolene Impurity 3 | 2-[1-(Aminocarbonyl)-2-[[5-(4-nitrophenyl)-2-furanyl]methylene]hydrazinyl]-acetic Acid Ethyl Ester is an intermediate used in the synthesis of 1-(5-Phenylfurfurylideneamino)hydantoins. Synonyms: 2-[1-(Aminocarbonyl)-2-[[5-(4-nitrophenyl)-2-furanyl]methylene]hydrazinyl]-acetic Acid Ethyl Ester. Grades: > 95%. CAS No. 55227-60-6. Molecular formula: C16H16N4O6. Mole weight: 360.32. | |
| Dantrolene Sodium | Dantrolene sodium is a postsynaptic muscle relaxant that lessens excitation-contraction coupling in muscle cells. It suppresses the release of calcium previously sequestered by skeletal, but not cardiac, muscle sarcoplasmic reticulum. Synonyms: Dantrolene sodium salt; Dantrium; Sodium 3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-2-oxo-4H-imidazol-5-olate. Grades: 98.0%~102.0%. CAS No. 14663-23-1. Molecular formula: C14H9N4NaO5. Mole weight: 336.239. | |
| DAP-81 | DAP-81 is a diaminopyrimidine derivative that targets PLKs, destabilizing kinetochore microtubules. Other spindle tubules are stabilized, resulting in monopolar mitotic spindles. In vitro, DAP-81 inhibits Plk1 at an IC50 of 0.9 nM. DAP-81 is currently in ongoing preclinical evaluations. Synonyms: DAP81; DAP 81; DAP-81. N-(4-((4-((2-benzoylphenyl)amino)-5-nitropyrimidin-2-yl)amino)phenyl)acetamide. Grades: 98%. CAS No. 794466-17-4. Molecular formula: C25H20N6O4. Mole weight: 468.464. | |
| Dapagliflozin 2-O-β-D-Glucuronide | Dapagliflozin 2-O-β-D-Glucuronide is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-2-O-β-D-glucopyranuronosyl-D-glucitol. Grades: >95%. Molecular formula: C27H33ClO12. Mole weight: 585. | |
| Dapagliflozin 3-O-β-D-Glucuronide | Dapagliflozin 3-O-β-D-Glucuronide is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3-O-β-D-glucopyranuronosyl-D-glucitol; Dapagliflozin M-15 metabolite. Grades: > 95%. CAS No. 1351438-75-9. Molecular formula: C27H33ClO12. Mole weight: 585. | |
| Dapagliflozin C1,C2 Epimer | Dapagliflozin C1,C2 Epimer is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin C1,C2 Epimer Tetraacetate | Dapagliflozin C1,C2 Epimer Tetraacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin C2 Epimer Tetraacetate | Dapagliflozin C2 Epimer Tetraacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin Furanose Isomer | Dapagliflozin Furanose Isomer is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin 1,4-Anhydro impurity; (1S)-1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol. Grades: >95%. CAS No. 1469910-70-0. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin Impurity 1 | Dapagliflozin Impurity 1 is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Bromo Keto Impurity; (5-Bromo-2-Chlorophenyl)(2-Ethoxyphenyl)Methanone. Grades: > 95%. CAS No. 1404477-10-6. Molecular formula: C15H12BrClO2. Mole weight: 339.61. | |
| Dapagliflozin Impurity 10 | Dapagliflozin Impurity 10 is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Hydroxy Impurity; 1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose. Grades: >90%. CAS No. 960404-86-8. Molecular formula: C21H25ClO7. Mole weight: 424.87. | |
| Dapagliflozin Impurity 11 | Dapagliflozin Impurity 11 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Dimer. Molecular formula: C42H48Cl2O12. Mole weight: 815.73. | |
| Dapagliflozin Impurity 12 | Dapagliflozin Impurity 12 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C18H42O6Si4. Mole weight: 466.86. | |
| Dapagliflozin Impurity 13 | Dapagliflozin Impurity 13 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C21H25ClO6. Mole weight: 408.88. | |
| Dapagliflozin Impurity 14 | Dapagliflozin Impurity 14 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Ent-Dapagliflozin. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin Impurity 2 | Dapagliflozin Impurity 2 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 4-bromo-1-chloro-2-(2-ethoxybenzyl)benzene. Grades: >95%. CAS No. 1830346-16-1. Molecular formula: C15H14BrClO. Mole weight: 325.63. | |
| Dapagliflozin Impurity 20 | Dapagliflozin Impurity 20 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 4-Bromo-1-chloro-2-(4-methoxybenzyl)benzene; 2-(4-methoxybenzyl)-4-bromo-1-chlorobenzene. Grades: >95%. CAS No. 333361-51-6. Molecular formula: C14H12BrClO. Mole weight: 311.6. | |
| Dapagliflozin Impurity 21 | Dapagliflozin Impurity 21 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Dibromo compound. Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin Impurity 23 | Dapagliflozin Impurity 23 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Keto Impurity. Grades: >90%. CAS No. 2169998-23-4. Molecular formula: C21H23ClO7. Mole weight: 422.86. | |
| Dapagliflozin Impurity 25 | Dapagliflozin Impurity 25 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin Impurity 27 | Dapagliflozin Impurity 27 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C42H48Cl2O13. Mole weight: 831.73. | |
| Dapagliflozin Impurity 28 | Dapagliflozin Impurity 28 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Deschloro Impurity; (2S,3R,4R,5S,6R)-2-(3-(4-Ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (1S)-1,5-Anhydro-1-C-[3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol. Grades: >95%. CAS No. 2444702-80-9. Molecular formula: C21H26O6. Mole weight: 374.43. | |
| Dapagliflozin Impurity 29 | Dapagliflozin Impurity 29 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C36H39ClO7. Mole weight: 619.14. | |
| Dapagliflozin Impurity 30 | Dapagliflozin Impurity 30 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin C2 Epimer; (2S,3S,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 2133407-75-5. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin Impurity 31 | Dapagliflozin Impurity 31 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Methoxy Oxo-dapagliflozin. Molecular formula: C20H21ClO7. Mole weight: 408.83. | |
Our database is helping our users find suppliers everyday.
